about
Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagationA general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame.Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationSmall Interfering RNA Targeted to Hepatitis C Virus 5' Nontranslated Region Exerts Potent Antiviral EffectComparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C VirusHepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis CThe Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus InfectionInfluence of quasispecies on virological responses and disease severity in patients with chronic hepatitis CClinicopathologic correlates of hepatitis C virus in brain: A pilot studyVertical hepatitis C virus transmission: Main questions and answersCorrelates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009Automated liver elasticity calculation for MR elastographyEffects of paracentesis on hemodynamic parameters and respiratory function in critically ill patientsChronic hepatitis C treatment patterns in African American patients: an update.Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.Sociodemographic trends in national ambulatory care visits for hepatitis C virus infectionFavorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C.Neurocognitive effects of HIV, hepatitis C, and substance use historySH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.Validation of the MOS-HIV as a measure of health-related quality of life in persons living with HIV and liver disease.Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studiesPrisons as social determinants of hepatitis C virus and tuberculosis infections.A novel duplex real-time reverse transcriptase-polymerase chain reaction assay for the detection of hepatitis C viral RNA with armored RNA as internal control.Lack of association between hepatitis C infection and chronic kidney diseaseTreatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis CAssociations between serum lipids and hepatitis C antiviral treatment efficacy.RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cellsSaponin inhibits hepatitis C virus propagation by up-regulating suppressor of cytokine signaling 2Clinical use of anti-TNF therapy and increased risk of infectionsPredicting the probable outcome of treatment in HCV patients.Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004.Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population.Current and future disease progression of the chronic HCV population in the United States.Age cohort differences in illicit drug use and hepatitis C among African American substance usersPredictors of spontaneous viral clearance and outcomes of acute hepatitis C infectionClinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.
P2860
Q24339370-E78BA851-54CA-472A-857D-F82478546AC9Q25255565-4E11CAE3-6615-42F9-8792-00AFA9C901D4Q26748571-AC114EB7-2FCA-478A-ABE7-308C1D9E3F9AQ26827517-37C03CDE-33A2-4027-B086-F489448253B7Q27024231-3EE2F0C0-317C-49E9-B1AC-13BEB1CF8BB7Q27478036-0E1B17F6-F071-449D-A8C1-B63EB94FB2C5Q27481004-3E66C258-A503-45E0-8C9E-DD8CCD73F7A1Q27486537-EA661A18-9260-4833-9D50-8F8516E7722FQ27486939-85E74F76-A64F-4073-B80E-3C1C64F4FC56Q27488410-2C34432F-D6E2-42C4-B41B-94CA326068D3Q27489380-A0795F30-65D8-408F-B2B7-B9F12ECC4B0BQ28248241-C6432D44-6188-4EA4-9FE0-E36C5BE69756Q28546457-F216BFF5-61D6-4DD2-974D-317403C86B8BQ30357722-B1F2E3C8-CCE3-41E7-A971-2BE45B0FD799Q31148915-3AFBA1D8-7069-49AD-A11D-9273045C4E03Q33212476-16E277E0-9CC9-4989-A16B-AEE01311E05CQ33388034-406251C8-EFB4-4FD4-BB41-B273F95C968FQ33395403-71A107A5-7DF0-40B7-B45D-8017BAE07752Q33424681-09492772-225A-4741-B5B9-52105A58B019Q33652957-49336784-27C0-4FF9-964F-D1BE569DF3B5Q33719537-66D0D573-7971-4F72-BE15-C6DEC60FEBC4Q33824530-CC525485-5D22-4455-84CB-2AC458ECAAACQ33872878-37A68640-9447-474F-A683-F7F5ABBB6A56Q33902953-7D880703-94F8-48F5-BF2F-256446310C6CQ33991980-E8DD3D9B-93BB-4808-8E4C-DFE45E9976EDQ34034846-69B5E0D2-A2A7-481B-9CF0-15B930174BAAQ34113801-E6303829-5749-4D03-B391-AA32624CF5BBQ34124888-F65BA240-6521-4425-8C86-1D539D10C76EQ34178401-0EFDB9DD-F6D5-4932-B4C9-821C99012490Q34321357-E2DE2237-2E86-49F7-A37B-06B3121654C1Q34338096-32B6FEA5-4EE5-4B3C-9041-B1363E550FE5Q34409039-467D1FDE-8910-4E6B-A630-3EEC71126B4EQ34624732-A20521B4-522C-489E-AB63-1BDDC0656BFDQ34638892-949B7253-1D96-4E99-B0B1-FAE107115498Q34686844-E6DFEBA5-A1F2-4549-8737-9C7D14449F91Q34694441-9A9F693F-B5FC-4C3F-B274-E4CA335C1211Q34737843-FEB7F763-065F-4A7C-90FB-45439D000DE8Q34765207-E618BBEA-B0B5-4F0D-8358-9D82FBC0A62AQ34779758-C4450A31-48C7-4F67-8E63-9C6C72C58F91Q34873114-BDD8E986-AEFF-44DC-A0DD-B6BDFE5FB876
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The burden of hepatitis C in the United States.
@ast
The burden of hepatitis C in the United States.
@en
The burden of hepatitis C in the United States.
@nl
type
label
The burden of hepatitis C in the United States.
@ast
The burden of hepatitis C in the United States.
@en
The burden of hepatitis C in the United States.
@nl
prefLabel
The burden of hepatitis C in the United States.
@ast
The burden of hepatitis C in the United States.
@en
The burden of hepatitis C in the United States.
@nl
P2860
P356
P1433
P1476
The burden of hepatitis C in the United States.
@en
P2093
P2860
P356
10.1053/JHEP.2002.36791
P407
P433
P577
2002-11-01T00:00:00Z